Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on July 26, 2021. The report discloses corporate governance changes, specifically the election of a new member to the Board of Directors.
Key Financial Metrics
The filing does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a director and does not contain financial statements or performance metrics.
Material Changes
On July 22, 2021, Myriam Curet, M.D., was elected to the Board of Directors. There are no arrangements between Ms. Curet and other persons regarding her selection. She will receive compensation on the same basis as other non-management directors. The Company confirmed no transactions exceeding $120,000 since January 1, 2020, in which Ms. Curet had a material interest.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding future activities and performance, noting they are subject to risks and uncertainties. No specific business guidance, outlook, or new risk factors were disclosed in this report. The information is furnished under Regulation FD and is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the background and qualifications of the newly elected director, Myriam Curet, M.D.
- Review the attached Press Release (Exhibit 99.1) for additional context on the board expansion.
- Confirm that no undisclosed related-party transactions exist involving the new director.
- Note that this filing contains no financial updates; refer to recent 10-Q or 10-K filings for financial performance.